STAFF PROFILE
Professor Melissa Churchill
Position:
Professor
College / Portfolio:
Biomedical Science Cluster
School / Department:
CIID Research Program
Phone:
99256657
Campus:
Bundoora Campus
Contact me about:
Research supervision
- Roche, M.,Tumpach, C.,Symons, J.,Gartner, M.,Anderson, J.,Khoury, G.,Cashin, K.,Cameron, P.,Churchill, M.,Deeks, S.,Gorry, P.,Lewin, S. (2020). CXCR4-using HIV strains predominate in na�ve and central memory CD4(+) T cells in people living with HIV on antiretroviral therapy: implications for how latency is established and maintained In: Journal of virology, 94, 1 - 1
- Angelovich, T.,Churchill, M.,Wright, E.,Brew, B. (2020). (In Press) New Potential Axes of HIV Neuropathogenesis With Relevance to Biomarkers and Treatment In: Current Topics in Behavioral Neurosciences, , 1 - 37
- Moso, M.,Anderson, J.,Adikari, S.,Churchill, M., et al, . (2019). HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal In: AIDS, 33, 199 - 209
- Bertram, K.,Botting, R.,Baharlou, H.,Churchill, M., et al, M. (2019). Identification of HIV transmitting CD11c+ human epidermal dendritic cells In: Nature Communications, 10, 1 - 15
- Wang, H.,Blackall, M.,Sominsky, L.,Spencer, S.,Vlahos, R.,Churchill, M.,Bozinovski, S. (2018). Increased hypothalamic microglial activation after viral-induced pneumococcal lung infection is associated with excess serum amyloid A production In: Journal of Neuroinflammation, 15, 1 - 11
- Chang, C.,Naranbhai, V.,Stern, J.,Roche, M.,Churchill, M., et al., . (2018). Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1 In: AIDS, 32, 2119 - 2128
- Flynn, J.,Ellenberg, P.,Duncan, R.,Ellett, A.,Zhou, J.,Sterjovski, J.,Cashin, K.,Borm, K.,Gray, L.,Lewis, M.,Jubb, B.,Westby, M.,Lee, B.,Lewin, S.,Churchill, M.,Roche, M.,Gorry, P. (2017). Analysis of clinical HIV-1 strains with resistance to maraviroc reveals strain-specific resistance mutations, variable degrees of resistance, and minimal cross-resistance to other CCR5 antagonists In: AIDS Research and Human Retroviruses, 33, 1220 - 1235
- Gray, L.,Brew, B.,Churchill, M. (2016). Strategies to target HIV-1 in the central nervous system In: Current Opinion in HIV and AIDS, 11, 371 - 375
- Meikle, P.,Low, H.,Churchill, M.,Bukrinsky, M.,Sviridov, D. (2016). Lipidomic dataset of plasma from patients infected with wild type and nef-deficient HIV-1 strain In: Data in Brief, 6, 168 - 175
- Low, H.,Cheng, L.,Di Yacovo, M.,Churchill, M.,Meikle, P.,Bukrinsky, M.,Hill, A.,Sviridov, D. (2016). Lipid metabolism in patients infected with Nef-deficient HIV-1 strain In: Atherosclerosis, 244, 22 - 28
5 PhD Current Supervisions and 1 Masters by Research Current Supervisions
- Defining HIV-1 Reservoirs in the Central Nervous System. Funded by: National Health and Medical Research Council Ideas Grants from (2020 to 2022)
- Characterising the role of epigenetic marks in driving monocyte-derived foam cell formation associated with atherosclerosis in ageing individuals. Funded by: Rebecca L. Cooper Medical Research Foundation - Competitive from (2020 to 2023)
- Developing novel drug delivery strategies to target myeloid reservoirs of HIV in the brain. Funded by: WMIMR Australian Centre for HIV and Hepatitis Virology Research Grant (ACH2) 2018 onwards from (2020 to 2021)
- Elucidating the mechanisms driving the pathophysiology of HIV-associated neurocognitive disorders. Funded by: NHMRC Project Grants 2018 from (2019 to 2021)
- Defining HIV reservoirs in the central nervous system. Funded by: Jack Brockhoff Foundation Medical Grant 2017 onwards from (2018 to 2021)